$3.15
▼ $0.02 (-0.6%)
MYGN
Myriad Genetics Inc. Common Stock
Health Care
Investor Score
39F
Weak rating
Based on 7 of 7 weighted categories, computed from real, live financial data only.
6
Technical
39
Fundamental
32
Growth
50
Fair Value
86
News
63
Quality
54
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.